Beyond Conventional MRI: Molecular PET, Multiparametric MRI, and PET/MRI in Glioma Management
Diagnostics · 04.11.2026 · 16 (21) · 3641
DOI: 10.3390/diagnostics16213641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 04.11.2026. Verfasst von Shu-Hang Ng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan 333423, T…. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council of Taiwan, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
Despite its central clinical role, conventional magnetic resonance imaging (MRI) provides an incomplete picture of the tumor biology of gliomas, which are biologically heterogeneous tumors. Molecular positron emission tomography (PET) with amino acid tracers, multiparametric MRI techniques (perfusion-, diffusion-, and spectroscopy-based sequences), and hybrid PET/MRI have each been proposed to overcome specific limitations of anatomic imaging in diagnosis, treatment planning, and posttreatment assessment. This narrative review examined the current evidence for molecular PET, multiparametric MRI, and integrated PET/MRI across the glioma care pathway. Rather than framing these modalities as competing alternatives, we argue that amino acid transport, vascularity, water diffusion, and metabolite composition capture distinct and often spatially incongruent facets of tumor biology, such that discordance between modalities may reflect the underlying tumor heterogeneity. We also summarized the guideline recommendations (RANO/EANO, EANM/SNMMI, etc.), outlined current evidence gaps, and discussed emerging directions in novel PET tracers, artificial intelligence, radiomics, and theranostics. Molecular PET and multiparametric MRI should be used as modalities complementary to conventional MRI within multidisciplinary glioma care, while the choice and sequence of examinations should be guided by the clinical question.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan 333423, Taiwan.
- Department of Medical Imaging, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970423, Taiwan.
- Department of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970423, Taiwan.
- School of Medicine, College of Medicine, Tzu Chi University, Hualien 970423, Taiwan.
- Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970423, Taiwan.
ORCID-Profile: Shu-Hang Ng, Sheng-Tzung Tsai
Förderung
- National Science and Technology Council of Taiwan
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Ng, S. H., Siow, T. Y., Kao, H. W., Chan, S. C., & Tsai, S. T. (2026). Beyond Conventional MRI: Molecular PET, Multiparametric MRI, and PET/MRI in Glioma Management. Diagnostics, 16(21), 3641. https://doi.org/10.3390/diagnostics16213641
Vancouver
Ng SH, Siow TY, Kao HW, Chan SC, Tsai ST. Beyond Conventional MRI: Molecular PET, Multiparametric MRI, and PET/MRI in Glioma Management. Diagnostics. 2026;16(21):3641. doi:10.3390/diagnostics16213641
BibTeX
@article{Ng2026,
author = {Ng, Shu-Hang and Siow, Tiing-Yee and Kao, Hung-Wen and Chan, Sheng-Chieh and Tsai, Sheng-Tzung},
title = {Beyond Conventional MRI: Molecular PET, Multiparametric MRI, and PET/MRI in Glioma Management},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3641},
doi = {10.3390/diagnostics16213641}
}
EUVIMED